Beratis N G, Mavrommatis T, Hatiris I, Kavaliotis J, Tsagaropoulou-Stiga H, Syrogiannopoulos G A
Department of Pediatrics, University of Patras, School of Medicine, General University Hospital, Patras, Greece.
Pediatr Res. 1997 Feb;41(2):235-41. doi: 10.1203/00006450-199702000-00014.
Because inflammation could affect lysosomal enzyme trafficking, resulting in increased enzyme release from the cells, tissue necrosis, or altered blood- and the brain-cerebrospinal fluid (CSF) barrier, the activity of four lysosomal enzymes in the cell-free CSF of 34 patients with bacterial meningitis, 20 with aseptic meningitis, and 39 control subjects was measured. Activities are expressed in nanomoles of 4-methylumbelliferone mL/h. The median beta-hexosaminidase A activity in bacterial meningitis was 313, in aseptic meningitis it was 173, and in the control subjects it was 175, the median beta-hexosaminidase B activity was 417, 165, and 120; the median alpha-mannosidase activity was 171, 124, and 113; and the median beta-glucuronidase activity was 133.7, 14.3, and 10.0, respectively. The difference of the activities of the four enzymes measured between the bacteria meningitis and the controls is significant (p < 0.000). Also significant is the difference between bacterial and aseptic meningitis (p = 0.005 to < 0.000), but it is not significant between aseptic and control subjects. Both the sensitivity and specificity of the beta-glucuronidase activity between bacterial meningitis and control subjects were 100%, whereas the corresponding values between bacterial and aseptic meningitis were 100% and 90%, respectively. No significant correlation was observed between the activities of the enzymes measured and the number of the polymorphonuclear leukocytes or other laboratory characteristics of the CSF. The increased lysosomal enzyme activities in the CSF of patients with meningitis may result from diffusion across the blood-CSF or the brain-CSF barrier or from enzyme leakage through the cell membranes.
由于炎症会影响溶酶体酶的运输,导致细胞内酶释放增加、组织坏死,或改变血脑屏障和脑脊髓液(CSF)屏障,因此对34例细菌性脑膜炎患者、20例无菌性脑膜炎患者和39例对照者的无细胞脑脊液中四种溶酶体酶的活性进行了测定。活性以每毫升每小时4-甲基伞形酮的纳摩尔数表示。细菌性脑膜炎患者中β-己糖胺酶A活性的中位数为313,无菌性脑膜炎患者中为173,对照者中为175;β-己糖胺酶B活性的中位数分别为417、165和120;α-甘露糖苷酶活性的中位数分别为171、124和113;β-葡萄糖醛酸酶活性的中位数分别为133.7、14.3和10.0。细菌性脑膜炎与对照者之间所测四种酶的活性差异具有显著性(p<0.000)。细菌性脑膜炎与无菌性脑膜炎之间的差异也具有显著性(p=0.005至<0.000),但无菌性脑膜炎与对照者之间差异不显著。细菌性脑膜炎与对照者之间β-葡萄糖醛酸酶活性的敏感性和特异性均为100%,而细菌性脑膜炎与无菌性脑膜炎之间相应的值分别为100%和90%。所测酶的活性与脑脊液中多形核白细胞数量或其他实验室特征之间未观察到显著相关性。脑膜炎患者脑脊液中溶酶体酶活性增加可能是由于酶通过血脑屏障或脑脊髓液屏障扩散,或通过细胞膜渗漏所致。